APUS Financials

Apimeds Pharmaceuticals Us Inc - Financial statements & key metrics

Stock Price

$1.88

Market Cap

$23.64M

EPS

$-0.41

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-1.39M

EPS (Diluted)

$-0.18

Balance Sheet Highlights

Total Assets

$13,057

Total Liabilities

$1.37M

Shareholders Equity

Cash & Equivalents

$3,455

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-733,526

CapEx

Free Cash Flow

Profitability Metrics

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is APUS revenue?

View APUS's income statement for detailed revenue data.

Is APUS profitable?

APUS reported a loss of $1.39M in the most recent quarter.

What is APUS market cap?

APUS has a market capitalization of $23.64M, making it a small-cap stock.

Does APUS have debt?

View APUS's balance sheet for debt information.

What is APUS cash flow?

Cash flow data is available in the full financial statements.